Cancer Therapy: Preclinical SAR650984, A Novel Humanized CD38-Targeting Antibody, Demonstrates Potent AntitumorActivity inModels ofMultiple Myeloma and Other CD38þ Hematologic Malignancies
暂无分享,去创建一个
C. Dumontet | P. Ferrari | V. Goldmacher | L. Bartle | A. Skaletskaya | Q. Zhou-Liu | C. Lahoute | P. Lejeune | Jutta Deckert | E. Wetzel | François Vall | ephanie Pouzieux | AdrianaPlesa | MarielleChiron | ThomasChittenden | Peter U Park | Anna Skaletskaya